Elena Gkrouzman

[Tatiana Prowell, MD @tmprowell]

If you have a US residential address, you can order 8 more free #COVID19 home rapid tests here in about 30 seconds (on top of 8 previously allowed). No credit card needed. Shipped via USPS for free. #MedTwitter

https://t.co/aznLD04CcR

[Elena Gkrouzman @gkrouzman]

@jasonsknight I always seem to come back to this one:
https://t.co/uEnBRP33F7

[StressieBessie @EPrecipice]

When talking about our agendas for the day, I told my 5yo I was a little nervous about a meeting I have today. He said, “Mama, I am nervous all the time. I know what to do.” So friends, here is all the advice he could fit into the drive to school:

[Doruk Erkan @DorukErkanMD]

A historical paper by @jasonsknight 20 years after our first report of defibrotide use in #APS; also in honor of the late Dr Ronald Asherson.

[Elena Gkrouzman @gkrouzman]

@DoctorHamdyA Try @EBRheum podcast. Awesome work.

[UMass Lupus @UMassLupus]

Hi everyone, we are co-organizing a free virtual #Lupus Medical and Educational Symposium with @LupusNE ! Please consider attending 💜
Tagging UMass team @rashighi @gkrouzman @tcelltracker #AnnMarshak-Rothstein

[Doruk Erkan @DorukErkanMD]

Our most recent top 10 series patient article: APS & Skin Problems https://t.co/57ym0zBxQU

[APS_ACTION @APS_ACTION]

APS ACTION PUBLICATION (December 2020). An article summary for patients by Dr Elena Gkrouzman @gkrouzman is also included @ https://t.co/LeAHTiBvVs. Antiphospholipid Antibody Profile Stability Over Time: Prospective Results from APS ACTION Registry.

[Elena Gkrouzman @gkrouzman]

@MariaTektonidou Congratulations!! Well-deserved!

[Laurent ARNAUD @Lupusreference]

For those who haven't checked it yet 😲: have a look my video 📺 about the #history of #lupus! 🐺More than 200 hours of research in historical archives 👨‍🎓 summarized in 18 minutes ⏱️
#LupusAwarenessMonth
#Lupusawareness
https://t.co/eMfhGEcm9L

[Doruk Erkan @DorukErkanMD]

Our most recent top 10 series patient article: APS & COVID-19 https://t.co/LGcSkY9ke7

[Casanova Lab @casanova_lab]

We have been silent for a while because our lab and the CHGE were entirely focused on finishing 'twin papers' in @ScienceMagazine about inborn errors of type I IFN or auto-antibodies to type I IFN in nearly 15% of patients with life-threatening #COVID19 😀 https://t.co/E85pF1Kg88